ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 41.43% of INAB shares are held by financial institutions. UBS GROUP AG is the top corporate investor, holding 0 shares valued at -. A 0% stake in IN8bio, Inc. is owned by the company. STONEGATE INVESTMENT GROUP, LLC owns 180K shares valued at $212.40K, which translates its holding of 0.6% of the stake in the company.
Among the INAB insiders holding of 14.09% of the stake in company, TRANSCEND PARTNERS OPPORTUNITY FUND LLC, , holds the largest shares of 4.11M. CAVU ADVISORS, LLC, , is the second largest INAB insider with ownership of 3.65M shares. BIOS ADVISORS GP, LLC, , stands third with possession of 3.61M shares of that stake.